Logo image of MDB

MONGODB INC (MDB) Stock Fundamental Analysis

NASDAQ:MDB - Nasdaq - US60937P1066 - Common Stock - Currency: USD

189.36  +0.91 (+0.48%)

After market: 190.5 +1.14 (+0.6%)

Fundamental Rating

4

Taking everything into account, MDB scores 4 out of 10 in our fundamental rating. MDB was compared to 82 industry peers in the IT Services industry. While MDB has a great health rating, there are worries on its profitability. MDB is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MDB had positive earnings in the past year.
In the past year MDB had a positive cash flow from operations.
In the past 5 years MDB always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: MDB reported negative operating cash flow in multiple years.
MDB Yearly Net Income VS EBIT VS OCF VS FCFMDB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

The Return On Assets of MDB (-3.76%) is worse than 63.41% of its industry peers.
MDB has a Return On Equity (-4.64%) which is in line with its industry peers.
Industry RankSector Rank
ROA -3.76%
ROE -4.64%
ROIC N/A
ROA(3y)-7.75%
ROA(5y)-10.95%
ROE(3y)-22.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDB Yearly ROA, ROE, ROICMDB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20K 40K 60K 80K

1.3 Margins

Looking at the Gross Margin, with a value of 73.32%, MDB belongs to the top of the industry, outperforming 89.02% of the companies in the same industry.
In the last couple of years the Gross Margin of MDB has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for MDB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y0.85%
MDB Yearly Profit, Operating, Gross MarginsMDB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

8

2. Health

2.1 Basic Checks

MDB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MDB has more shares outstanding
Compared to 5 years ago, MDB has more shares outstanding
MDB has a better debt/assets ratio than last year.
MDB Yearly Shares OutstandingMDB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
MDB Yearly Total Debt VS Total AssetsMDB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

An Altman-Z score of 14.71 indicates that MDB is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 14.71, MDB belongs to the best of the industry, outperforming 93.90% of the companies in the same industry.
MDB has a debt to FCF ratio of 0.31. This is a very positive value and a sign of high solvency as it would only need 0.31 years to pay back of all of its debts.
The Debt to FCF ratio of MDB (0.31) is better than 87.80% of its industry peers.
MDB has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
MDB has a better Debt to Equity ratio (0.01) than 82.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.31
Altman-Z 14.71
ROIC/WACCN/A
WACC9.63%
MDB Yearly LT Debt VS Equity VS FCFMDB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

MDB has a Current Ratio of 5.20. This indicates that MDB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MDB (5.20) is better than 93.90% of its industry peers.
A Quick Ratio of 5.20 indicates that MDB has no problem at all paying its short term obligations.
The Quick ratio of MDB (5.20) is better than 93.90% of its industry peers.
Industry RankSector Rank
Current Ratio 5.2
Quick Ratio 5.2
MDB Yearly Current Assets VS Current LiabilitesMDB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.27% over the past year.
MDB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.22%.
Measured over the past years, MDB shows a very strong growth in Revenue. The Revenue has been growing by 36.61% on average per year.
EPS 1Y (TTM)10.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.84%
Revenue 1Y (TTM)19.22%
Revenue growth 3Y31.93%
Revenue growth 5Y36.61%
Sales Q2Q%19.74%

3.2 Future

Based on estimates for the next years, MDB will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.49% on average per year.
MDB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.55% yearly.
EPS Next Y-27.96%
EPS Next 2Y-3.4%
EPS Next 3Y7.16%
EPS Next 5Y17.49%
Revenue Next Year15.02%
Revenue Next 2Y15.78%
Revenue Next 3Y16.55%
Revenue Next 5Y16.55%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MDB Yearly Revenue VS EstimatesMDB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
MDB Yearly EPS VS EstimatesMDB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 51.88 indicates a quite expensive valuation of MDB.
Compared to the rest of the industry, the Price/Earnings ratio of MDB is on the same level as its industry peers.
MDB's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.20.
The Price/Forward Earnings ratio is 72.02, which means the current valuation is very expensive for MDB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MDB is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.13. MDB is valued rather expensively when compared to this.
Industry RankSector Rank
PE 51.88
Fwd PE 72.02
MDB Price Earnings VS Forward Price EarningsMDB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDB is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 128.25
EV/EBITDA N/A
MDB Per share dataMDB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.4%
EPS Next 3Y7.16%

More info and screens

0

5. Dividend

5.1 Amount

MDB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONGODB INC

NASDAQ:MDB (5/29/2025, 8:00:00 PM)

After market: 190.5 +1.14 (+0.6%)

189.36

+0.91 (+0.48%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)06-04 2025-06-04/amc
Inst Owners92.88%
Inst Owner Change20.58%
Ins Owners0.77%
Ins Owner Change2.48%
Market Cap15.47B
Analysts80
Price Target279.44 (47.57%)
Short Float %3.58%
Short Ratio1.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)78.84%
Min EPS beat(2)66.15%
Max EPS beat(2)91.53%
EPS beat(4)4
Avg EPS beat(4)56.31%
Min EPS beat(4)27.24%
Max EPS beat(4)91.53%
EPS beat(8)8
Avg EPS beat(8)86.45%
EPS beat(12)12
Avg EPS beat(12)163.56%
EPS beat(16)16
Avg EPS beat(16)137.13%
Revenue beat(2)2
Avg Revenue beat(2)4.9%
Min Revenue beat(2)4.5%
Max Revenue beat(2)5.3%
Revenue beat(4)4
Avg Revenue beat(4)3.31%
Min Revenue beat(4)1.47%
Max Revenue beat(4)5.3%
Revenue beat(8)8
Avg Revenue beat(8)4.48%
Revenue beat(12)12
Avg Revenue beat(12)5.29%
Revenue beat(16)16
Avg Revenue beat(16)5.92%
PT rev (1m)-10.05%
PT rev (3m)-24.91%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)6.28%
EPS NY rev (1m)0.03%
EPS NY rev (3m)-22.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-2.21%
Valuation
Industry RankSector Rank
PE 51.88
Fwd PE 72.02
P/S 7.71
P/FCF 128.25
P/OCF 103.02
P/B 5.56
P/tB 5.76
EV/EBITDA N/A
EPS(TTM)3.65
EY1.93%
EPS(NY)2.63
Fwd EY1.39%
FCF(TTM)1.48
FCFY0.78%
OCF(TTM)1.84
OCFY0.97%
SpS24.56
BVpS34.05
TBVpS32.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.76%
ROE -4.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.32%
FCFM 6.01%
ROA(3y)-7.75%
ROA(5y)-10.95%
ROE(3y)-22.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y0.85%
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.31
Debt/EBITDA N/A
Cap/Depr 187.92%
Cap/Sales 1.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.2
Quick Ratio 5.2
Altman-Z 14.71
F-Score5
WACC9.63%
ROIC/WACCN/A
Cap/Depr(3y)83.49%
Cap/Depr(5y)72.21%
Cap/Sales(3y)0.8%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.84%
EPS Next Y-27.96%
EPS Next 2Y-3.4%
EPS Next 3Y7.16%
EPS Next 5Y17.49%
Revenue 1Y (TTM)19.22%
Revenue growth 3Y31.93%
Revenue growth 5Y36.61%
Sales Q2Q%19.74%
Revenue Next Year15.02%
Revenue Next 2Y15.78%
Revenue Next 3Y16.55%
Revenue Next 5Y16.55%
EBIT growth 1Y7.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.27%
EBIT Next 3Y15.29%
EBIT Next 5Y36.16%
FCF growth 1Y4.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.64%
OCF growth 3Y178.14%
OCF growth 5YN/A